Effect of long-term treatment with trivalent chromium on erythropoietin production in HepG2 cells
Archives of Biochemistry and Biophysics · 2024
DOI: 10.1016/j.abb.2023.109872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024. Verfasst von Kazuhiko Nishimura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Bioenvironmental Sciences, Course of Veterinary Science, Graduate School of Veterinary Science, Osaka Metropolitan University, 1-58 Rin…. Hauptthemen laut MEDLINE: PPAR gamma, Erythropoietin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Trivalent chromium (Cr(III)) is sometimes taken as a long-term supplement, but its effectiveness is unclear. Recently, Cr(III) reportedly modulates peroxisome proliferator-activated receptor gamma (PPARγ) expression. Our previous study reported that increased PPARγ after 24 h Cr(III) treatment promoted erythropoietin (EPO) production in HepG2 cells. In the current study, we analyzed 4-week Cr(III) treatment effects on PPARγ and EPO production in HepG2 cells. Long-term Cr(III) treatment resulted in significantly elevated mRNA expression levels of PPARγ and EPO compared to controls. Additionally, treatment with a PPARγ inhibitor suppressed EPO mRNA expression. Increased EPO mRNA expression due to stimulation with hypoxia or cobalt was unaffected by long-term Cr(III) treatment. Administration of lipopolysaccharide and pyocyanin which causes oxidative stress, promoted EPO production, but this effect was attenuated in cells treated with Cr(III). Long-term Cr(III) treatment increased hypoxia inducible factor (HIF)-1α and 2α mRNA expression and protein levels. Increased PPARγ, induced by long-term Cr(III) treatment, suppressed sirtuin1 (SIRT1) mRNA expression and increased EPO mRNA expression, suggesting that increased PPARγ attenuated the suppressive effect of SIRT1 on HIF. These results suggest that the sustained increase in PPARγ during long-term Cr(III) treatment maintains increased EPO production through a mechanism different from that observed under hypoxia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Bioenvironmental Sciences, Course of Veterinary Science, Graduate School of Veterinary Science, Osaka Metropolitan University, 1-58 Rinku Ohrai-Kita, Izumisano, Osaka, 598-8531, Japan. Electronic address:…
- Laboratory of Bioenvironmental Sciences, Course of Veterinary Science, Graduate School of Veterinary Science, Osaka Metropolitan University, 1-58 Rinku Ohrai-Kita, Izumisano, Osaka, 598-8531, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Nishimura, K., Iitaka, S., Sakaki, T., Tsuji, K., Yoshimoto, A., Haque, M. A., & Nakagawa, H. (2024). Effect of long-term treatment with trivalent chromium on erythropoietin production in HepG2 cells. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2023.109872
Vancouver
Nishimura K, Iitaka S, Sakaki T, Tsuji K, Yoshimoto A, Haque MA, et al. Effect of long-term treatment with trivalent chromium on erythropoietin production in HepG2 cells. Archives of Biochemistry and Biophysics. 2024. doi:10.1016/j.abb.2023.109872
BibTeX
@article{Nishimura2024,
author = {Nishimura, Kazuhiko and Iitaka, Suzuka and Sakaki, Takuya and Tsuji, Keigo and Yoshimoto, Akari and Haque, Md Anamul and Nakagawa, Hiroshi},
title = {Effect of long-term treatment with trivalent chromium on erythropoietin production in HepG2 cells},
journal = {Archives of Biochemistry and Biophysics},
year = {2024},
doi = {10.1016/j.abb.2023.109872}
}
EUVIMED